Spots Global Cancer Trial Database for precancerous conditions
Every month we try and update this database with for precancerous conditions cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Cervical Cancer Prevention: From DNA to mRNA? - New Technologies for Cervical Cancer Screening 2 | NCT01837693 | Precancerous Co... Neoplasms | Experimental: i... | 25 Years - 59 Years | Azienda Unità Sanitaria Locale Reggio Emilia | |
Chemoprevention of Oral Premalignant Lesions | NCT00036283 | Precancerous Co... | Celecoxib | 18 Years - | Pfizer | |
Chemoprevention of Oral Premalignant Lesions | NCT00036283 | Precancerous Co... | Celecoxib | 18 Years - | Pfizer | |
Helicobacter Pylori Eradication to Prevent Gastric Cancer | NCT01133951 | Helicobacter In... Stomach Neoplas... | OAC triple ther... Placebo | 30 Years - 59 Years | Second Military Medical University | |
Follow-up Modalities of Low Grade Precancerous Bronchial Lesions | NCT00213603 | Precancerous Co... Thoracic Neopla... | 18 Years - 80 Years | University Hospital, Rouen | ||
Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers | NCT03347838 | Bronchial Dyspl... Tobacco Smoking History of Non-... History of Head... | Nivolumab | 18 Years - 80 Years | University of Colorado, Denver | |
Collection of Blood, Bone Marrow, Tumor or Tissue Samples | NCT00043615 | Neoplasms Precancerous Co... | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004) | NCT03285490 | Actinic Keratos... | KX2-391 Ointmen... Placebo | 18 Years - | Almirall, S.A. | |
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis | NCT06001385 | Acute Lymphobla... Acute Myeloid L... Acute Leukemia Myelodysplastic... Chronic Myeloid... Chronic Lymphoc... Myeloproliferat... Lymphoma Chronic Myelomo... Pro-Lymphocytic... Myelofibrosis | Busulfan Fludarabine PBSC Hematopoie... Post-Transplant... Mesna Tacrolimus Mycophenolate M... Patient Reporte... Melphalan Total-body irra... Cyclophosphamid... | 18 Years - | Center for International Blood and Marrow Transplant Research | |
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004) | NCT03285490 | Actinic Keratos... | KX2-391 Ointmen... Placebo | 18 Years - | Almirall, S.A. | |
Photographic Evidence of Oral Precancerous Lesions in Current Tobacco and Areca Nut Users Improves Their Quit Rates | NCT05215860 | Precancerous Co... | Tobacco and are... visual exposure... | - | All India Institute of Medical Sciences, New Delhi | |
Efficacy and Safety of VDA-1102 Ointment in the Treatment of Actinic Keratosis | NCT02844777 | Actinic Keratos... | Placebo 5% VDA-1102 10% VDA-1102 | 18 Years - | Vidac Pharma | |
Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy | NCT00851305 | Stomach Neoplas... Precancerous Co... | Endomicroscope ... Gastroscopes (P... | 45 Years - 80 Years | Shandong University | |
Microwave Treatment for Actinic Keratosis | NCT05636800 | Keratosis, Acti... | Swift System | 18 Years - 85 Years | Blackwell Device Consulting | |
Sintilimab to Prevent High-risk Oral Premalignant Lesions Cancerization | NCT04065737 | Oral Cavity Can... Mouth Neoplasm Precancerous Co... | Sintilimab | 18 Years - | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | |
Oral Epithelial Dysplasia Informational Needs Questionnaire | NCT04153266 | Oral Epithelial... Precancerous Co... Precancerous Le... Oral Lichen Pla... Oral Leukoplaki... Oral Leukoplaki... Oral Leukoplaki... Oral Leukoplaki... Oral Erythropla... Chronic Hyperpl... Oral Submucous ... Oral Submucosal... Oral Disease Dental Diseases Dysplasia Information See... Patient Prefere... Information Nee... Health Behavior Quality of Life Preference, Pat... Patient Satisfa... Patient Engagem... Patient Partici... | No intervention... | 18 Years - | University College, London | |
A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp | NCT03285477 | Actinic Keratos... | Placebo KX2-391 Ointmen... | 18 Years - | Almirall, S.A. | |
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide | NCT04904588 | Acute Lymphobla... Acute Myelogeno... Mixed Phenotype... Acute Leukemia Myelodysplastic... Chronic Myeloge... Chronic Lymphoc... Lymphoma | Busulfan Busulfan Fludarabine Total-body irra... Cyclophosphamid... Melphalan PBSC Hematopoie... Bone Marrow Hem... Post-transplant... Mesna Tacrolimus Mycophenolate M... Patient-Reporte... | 1 Year - | Center for International Blood and Marrow Transplant Research | |
Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor | NCT00314262 | Precancerous Co... | Erlotinib & Cel... | 18 Years - 65 Years | Emory University | |
Identification of a Plasma Proteomic Signature for Lung Cancer | NCT01752101 | Precancerous Co... Carcinoma | 40 Years - | Integrated Diagnostics | ||
Identification of a Plasma Proteomic Signature for Lung Cancer | NCT01752101 | Precancerous Co... Carcinoma | 40 Years - | Integrated Diagnostics | ||
Natural History of Oro-pharyngeal Cancer Precursors | NCT00179361 | Precancerous Co... Leukoplakia Erythroplasia Oral Papillomas | 21 Years - | Albert Einstein College of Medicine | ||
Nivolumab for the Reversal of Squamous Dysplasia in High Risk Current and Former Smokers | NCT03347838 | Bronchial Dyspl... Tobacco Smoking History of Non-... History of Head... | Nivolumab | 18 Years - 80 Years | University of Colorado, Denver | |
Follow-up Modalities of Low Grade Precancerous Bronchial Lesions | NCT00213603 | Precancerous Co... Thoracic Neopla... | 18 Years - 80 Years | University Hospital, Rouen | ||
Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor | NCT00314262 | Precancerous Co... | Erlotinib & Cel... | 18 Years - 65 Years | Emory University |